On February 26, the phase I project of Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hutchison Whampoa traditional Chinese Medicine Co., Ltd. Chinese patent medicine intelligent manufacturing and warehousing logistics platform officially started construction in Guangzhou Pharmaceutical Industrial Park, Zhongluotan Town, Baiyun District, and is planned to be officially delivered for use by the end of 2024.
Xu Keyi, general manager of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hehuang traditional Chinese medicine, said that the warehouse built in phase I project will be equipped with intelligent three-dimensional warehouse system and intelligent logistics information system, which marks that Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hehuang traditional Chinese medicine officially launched enterprise digital transformation and innovation, and led the intelligent and industrial upgrading of the enterprise with digitization.
It is reported that the project plans to become a benchmark base for intelligent manufacturing of Chinese patent medicine in the industry and an industry-leading drug storage and logistics platform, and jointly form the North-South “wings” of intelligent manufacturing of finished Chinese medicine products with the company’s Bozhou production base.
During the 14th Five Year Plan period, the construction of intelligent logistics and intelligent production is an important part of China’s manufacturing power strategy. In this context, the production and manufacturing of traditional Chinese patent medicines also need to enter this field for innovation. Guangzhou Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hutchison Whampoa traditional Chinese medicine company represented by “Southern medicine” plans to invest a lot of money in intelligent transformation to demonstrate the industry.
So far, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hehuang traditional Chinese medicine has established two production bases in Guangzhou and Bozhou, Anhui, and gradually improved its national layout, taking into account the north and South markets.
In 2013, the company established Hutchison Huangpu traditional Chinese medicine (Bozhou) Co., Ltd. in Bozhou City, Anhui Province to build a production base. Bozhou is rich in Chinese herbal medicine resources. Many large-scale pharmaceutical enterprises have settled here, with obvious advantages in the pharmaceutical industry. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Hehuang traditional Chinese medicine defines Bozhou branch as the dual industry base of Great Southern medicine and great health. It is also its most important production base outside the province. After years of operation, it has developed into one of the largest tablet and granule production bases of Guangyao. The company’s famous and high-quality products Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) Compound Danshen Tablets and Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited(600332) compound Banlangen Granules are mainly produced in the base, accounting for about 60% of the market share of similar products in China.
This time, the company settled in Zhongluotan Town, Baiyun District, Guangzhou, and also valued the geographical location advantages and production intensive advantages here. These advantages will enable the production enterprises to realize the stability and controllability of the comprehensive cost of products.
